T. Rowe Price Investment Management, Inc. Merus N.V. Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Merus N.V. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 808,576 shares of MRUS stock, worth $35.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
808,576
Previous 830,268
2.61%
Holding current value
$35.9 Million
Previous $41.5 Million
18.03%
% of portfolio
0.02%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding MRUS
# of Institutions
202Shares Held
60.7MCall Options Held
111KPut Options Held
85.7K-
Rtw Investments, LP New York, NY4.17MShares$185 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$172 Million16.32% of portfolio
-
Wellington Management Group LLP Boston, MA3.5MShares$155 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.97MShares$132 Million3.1% of portfolio
-
Samlyn Capital, LLC New York, NY2.67MShares$118 Million1.81% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.04B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...